Clinical Trials

At The Skin Hospital we are committed to advancing the treatments and cures for skin diseases. Clinical Trials form a vital part of this process and are essential for the development of innovative and life changing medicine.
Clinical Trial – Atopic Dermatitis (Eczema)2019-12-03T14:57:02+11:00

Atopic Dermatitis (Eczema) Registration Form

  • Please review the information above before submitting. By submitting, you agree to our Privacy Statement

  • This field is for validation purposes and should be left unchanged.

Atopic Dermatitis (Eczema)

If you suffer from mild, moderate, or severe eczema, you may be eligible to participate in one of the eczema clinical trials at The Skin Hospital. 

Fill out the form on the left to register your interest. Our clinical trials coordinator will be in touch shortly to discuss your eligibility for the trial.
Upon receiving your consent, we can add your name and contact details to our database and contact you for upcoming trials.

Alternatively, ring us on 02 8279 2739 to speak to our clinical trials team today or email clinicaltrials@skinhospital.edu.au


Trial for Adults with Moderate to Severe Eczema

Participants: Aged 18-75 years old with moderate to severe eczema (atopic dermatitis)

Drug Type and Administration: Upadacitinib (by oral tablet) or dupilumab (by injection)

Status and Location: Currently recruiting at Darlinghurst

Additional information at ClinicalTrials.gov


Trial for Adolescents with Moderate to Severe Eczema

Participants: Aged 12-18 years old with moderate to severe eczema that has persisted for over one year

Drug Type and Administration: PF-04965842 (by oral tablet)

Status and Location: Currently recruiting at Westmead

             


Trial for Adolescents with Moderate to Severe Eczema

Participants: Aged 12-18 years old with moderate to severe eczema (atopic dermatitis)

Drug Type and Administration: Tralokinumab (by injection)

Status and Location: Currently recruiting at Darlinghurst

Additional information at ClinicalTrials.gov


Trial for Adults with Moderate to Severe Eczema

Participants: Adults with moderate to severe eczema (atopic dermatitis)

Drug Type and Administration: Baricitinib (oral tablet) and corticosteroid treatment (topical cream)

Status and Location: Currently recruiting at Westmead

Additional information at ClinicalTrials.gov


Trial for ages 12-70 years with Moderate Eczema

Participants: Aged 12–70 years old with moderate eczema (atopic dermatitis)

Drug Type and Administration: Cannabidiol by topical cream treatment (steroid free)

Status and Location: Currently recruiting at Westmead

Additional information at ANZCTR


Trial for 18+ with Mild to Severe Eczema

Participants: Aged 18 years or older with mild to severe eczema (atopic dermatitis)

Drug Type and Administration: Delgocitinib treatment (by topical cream)

Status and Location: Currently recruiting at Darlinghurst

Additional information at ANZCTR


Trial for 12+ with Moderate to Severe Eczema

Participants: Aged 12 years or older with moderate to severe eczema (atopic dermatitis)

Drug Type and Administration: Nemolizumab treatment (by injection)

Status and Location: Recruiting soon at Darlinghurst. Please register your interest Here.


Trial for Adults with Moderate to Severe Eczema

Participants: Adults with moderate to severe eczema (atopic dermatitis)

Drug Type and Administration: Baricitinib (by oral tablet)

Status: Active. Registrations currently closed.

Additional information at ClinicalTrials.gov 


Trial Extension for Adults who have undergone Baricitinib treatment

Paticipants: Adults with moderate to severe eczema (atopic dermatitis)

Drug Type and Administration: Baricitinib (by oral tablet)

Status: Active. Registrations currently closed.

Additional information at ClinicalTrials.gov


Trial for 18+ with Moderate to Severe Eczema

Participants: Aged 18 years or older with moderate to severe eczema (atopic dermatitis)

Drug Type and Administration: Tralokinumab monotherapy (by injection)

Status: Active. Registrations currently closed.

Additional information at ClinicalTrials.gov


MENU